Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer’s disease
The relationship between amyloid-β species and tau pathology in Alzheimer’s disease is not fully understood. Here, the authors show that it is the increased ratio of amyloid-β42 and 40 isoforms drives tau pathology in 3D human neural cell culture models of the disease.
Guardado en:
Autores principales: | Sang Su Kwak, Kevin J. Washicosky, Emma Brand, Djuna von Maydell, Jenna Aronson, Susan Kim, Diane E. Capen, Murat Cetinbas, Ruslan Sadreyev, Shen Ning, Enjana Bylykbashi, Weiming Xia, Steven L. Wagner, Se Hoon Choi, Rudolph E. Tanzi, Doo Yeon Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0c1c3533dcca447694dd527474cb0871 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
In vitro comparison of major memory-support dietary supplements for their effectiveness in reduction/inhibition of beta-amyloid protein fibrils and tau protein tangles: key primary targets for memory loss
por: Alan D. Snow, et al.
Publicado: (2021) -
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
por: Xue-Ning Shen, et al.
Publicado: (2021) -
MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
por: Chihiro Sato, et al.
Publicado: (2021) -
Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration
por: Marlies Gijs, et al.
Publicado: (2021) -
Accelerated inflammatory aging in Alzheimer’s disease and its relation to amyloid, tau, and cognition
por: Nicholas C. Cullen, et al.
Publicado: (2021)